← Glossary / Bone biology
Bone Health Glossary · Bone biology

Dickkopf-1

Also called: DKK1, Dkk-1 inhibitor

Evidence
✓ Established Science
Topic
Bone biology
Taught in
Tier 2 · Lesson 4
In plain English

What it means

Dickkopf-1 (DKK1) is a protein that blocks bone-building signals, and it's made in excess by some diseases like multiple myeloma to shut down new bone formation.

Why it matters for your bones

High DKK1 can silence your bone-building cells, which matters most if you have a condition like multiple myeloma that drives bone loss.

Dickkopf-1 (DKK1) is a protein made by cells in the body that acts as a brake on bone formation. It works by blocking the Wnt signaling pathway, a key communication system that tells bone-building cells (osteoblasts) to turn on and get to work. When DKK1 levels are high, that signal gets shut off.

Normally DKK1 helps keep bone remodeling balanced, but certain diseases push it into overdrive. Multiple myeloma, a cancer of plasma cells in the bone marrow, is a well-known example: myeloma cells pump out DKK1 along with sclerostin, which together paralyze osteoblasts while other signals from the cancer rev up bone-destroying osteoclasts. This mismatch — lots of breakdown, almost no rebuilding — creates the punched-out holes seen on imaging in myeloma bone disease.

Researchers study DKK1 as a potential marker and target in bone diseases, since blocking it in theory could let bone-building resume. This is an active area of science, not a home remedy or supplement decision — any treatment approach for bone loss tied to conditions like multiple myeloma belongs with your doctor or specialist, who can weigh the full picture, including medications like bisphosphonates or denosumab that are already used in that setting.

People also search
what is dickkopf-1 dkk1dkk1 and bone lossdkk1 multiple myelomadkk1 inhibitor bone diseasewnt signaling and osteoporosisdkk1 sclerostin difference
Evidence

How sure is this?

The research behind this
Established Science

Graded Established Science: Supported by broad scientific consensus and decades of research. Read each study with its grade in mind. One study is a piece of the picture, not the whole of it.

2 peer-reviewed studies, free with an Academy login
✦ The aha

DKK1 is a protein that can shut down bone-building signals, especially in diseases like multiple myeloma.

Your next step

Where this leads

108 discoveries so far
Word

You just read that DKK1 blocks bone-building signals. See the signaling system it interferes with that tells bone-building cells to switch on.

Wnt signaling pathway
Take me there Established Science
Go deeper

Where the Academy teaches it

This page is the short version. The lessons teach it in full, with the context around it and a quiz to lock it in.

Keep going

Related words

Wnt signaling pathway
Established Science

The Wnt signaling pathway is a cell-communication system that signals osteoblasts to build new bone; when it's…

Sclerostin
Established Science

Sclerostin is a protein made by bone cells called osteocytes that blocks new bone formation; less mechanical strain…

Multiple myeloma
Established Science

Multiple myeloma is a cancer of plasma cells in the bone marrow that disrupts the normal bone rebuilding process,…

RANKL
Strong Clinical Evidence

RANKL is a signal that activates osteoclasts, the cells that break down bone, and it's a key target for some…

OPG
Established Science

OPG (osteoprotegerin) is a protein made by bone-building cells that blocks a signal called RANKL, which helps slow…

Osteoblast
Established Science

An osteoblast is a cell that builds new bone by laying down fresh bone matrix, working alongside cells that break…

Education only, not medical advice. Decisions about tests, medications and treatment belong with your own doctor. OsteoStrong does not diagnose, treat or cure any disease.

Keep learning

More ways in